Arch Fam Med
Institution: CLOCKSS  | My Account | E-mail Alerts | Access Rights | Sign In
  Vol. 3 No. 11, November 1994 TABLE OF CONTENTS
 • Online Features
  Clinical Reviews
 This Article
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

A Critical Review of the New Oral Cephalosporins

Considerations and Place in Therapy

Daniel P. Rodman, pharmD; Jerry T. McKnight, MD; Russell L. Anderson, MD

Arch Fam Med. 1994;3(11):975-980.

Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.

1. Tomasz A. The mechanism of the irreversible antimicrobial effects of penicillins: how the betalactam antibiotics kill and lyse bacteria. Annu Rev Microbiol. 1979;33:113-137. PUBMED
2. Rodriquez WJ, Khan W, Sait T, et al. Cefixime vs cefaclor in the treatment of acute otitis media in children: a randomized, comparative study. Pediatr Infect Dis J. 1993;12:70-74. PUBMED
3. Kiani R, Johnson D, Nelson B. Comparative, multicenter studies of cefixime and amoxicillin in the treatment of respiratory tract infections. Am J Med. 1988;85(suppl3A):6-13. PUBMED
4. Irvani A, Richard G, Johnson D, Bryant A. A doubleblind, multicenter, comparative study of the safety and efficacy of cefixime versus amoxicillin in the treatment of urinary tract infections in adult patients. Am J Med. 1988;85(suppl 3A):17-23. PUBMED
5. Levenstein J, Summerfield PJF, Fourie S, et al. Comparison of cefixime and cotrimoxazole in acute uncomplicated urinary tract infection: a doubleblind general practice study. S Afr Med J. 1986;70:455-460. PUBMED
6. Handsfield HH, McCormack MD, Hook EW III, et al. A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. N Engl J Med. 1991;325:1337-1341. PUBMED
7. Aronovitz GH, Doyle CA, Durham SJ, et al. Cefprozil vs amoxicillin/clavulanate in the treatment of acute otitis media. Infect Med. 1992;9 (suppl C):19-32.
8. Poole JM, Rosenberg R, Aronovitz GH, et al. Cefprozil vs cefixime and cefaclor in otitis media in children. Infect Med. 1992;9(suppl E):21-32.
9. Doyle CA, Durham SJ, Hamilton HA, et al. Cefprozil vs cefaclor in the treatment of pharyngitis and tonsillitis in adults. Infect Med. 1992;9 (suppl E):66-67.
10. De la Garza CA, Nolen TM, Rogan MP. Cefprozil vs erythromycin in streptococcal tonsillopharyngitis. Infect Med. 1992;9(suppl E):8-20. PUBMED
11. Bonnet JP, Ginsberg O, Nolen TM, et al. Cefprozil vs cefuroxime axetil in mild to moderate lower respiratory tract infections: a focus on bronchitis. Infect Med. 1992;9(suppl E):48-56.
12. Barbarash RA, Solomon E, Thieneman A Jr, et al. Ceprozil vs amoxicillin/clavulanate in mild to moderate lower respiratory tract infections: a focus on bronchitis. Infect Med. 1992;9(suppl E):40-47.
13. Wachs G, Rogan MP, Cefprozil Multicenter Study Group. Cefprozil vs erythromycin for mild to moderate skin and skin structure infections. Infect Med. 1992;9(suppl E):57-65.
14. Solomon E, McCarty JM, Morman MR, et al. Comparison of cefprozil and amoxicillin/clavulanate potassium in the treatment of skin and skin structure infections in adults. Adv Ther. 1992;9:156-164.
15. Shiba K, Saito A, Shimada J, et al. Comparative clinical study of CS-807 and cefaclor for bacterial pneumonia by a double-blind method. Kansenshogaku Zasshi. 1988;62:973-1001. PUBMED
16. Zuck P, Riol U, lchou F. Efficacy and tolerance of cefpodoxime proxetil compared with ceftriaxone in vulnerable patients with bronchopneumonia. J Antimicrob Chemother. 1990;26(suppl E):71-77. FREE FULL TEXT
17. Mendelman PM, Del Beccaro MA, McLinn SE, Todd WM. Cefpodoxime proxetil compared with amoxicillin-clavulanate for the treatment of otitis media. J Pediatr. 1992;121:459-465. PUBMED
18. Dere WH, Farlow D, Therasse DG, Ruoff GE. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis. Clin Ther. 1992;14:41-53. PUBMED
19. Hyslop DL, Jacobson K, Guerra FJ. Loracarbef (LY163892) versus amoxicillin/clavulanate in bronchopneumonia and lobar pneumonia. Clin Ther. 1992;14:254-267. PUBMED
20. Nielsen RW. Acute bacterial maxillary sinusitis: results of US and European comparative trials. Am J Med. 1992;92(suppl 6A):70S-73S. PUBMED
21. Foshee WS. Loracarbef (LY163892) versus amoxicillin-clavulanate in the treatment of bacterial acute otitis media with effusion. J Pediatr. 1992;120:980-986. PUBMED
22. McCarty J. Loracarbef versus penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis in adult population. Am J Med. 1992;92 (suppl 6A):74S-79S. PUBMED
23. McCarty J, Ruoff GE, Jacobson KD. Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population. Am J Med. 1992;92(suppl6A):80S-85S. PUBMED
24. Irvani A. Loracarbef versus cefaclor in the treatment of urinary tract infections in women. Antimicrob Agents Chemother. 1991;35:750-752. FREE FULL TEXT
25. Hyslop DL, Bischoff W. Loracarbef (LY163892) versus cefaclor and norfloxin in the treatment of uncomplicated pyelonephritis. Am J Med. 1992;92(suppl 6A):86S-94S. PUBMED
26. Red Book. Oradell, NJ: Medical Economics Books; 1994.